Sunscreen regulation
This article was originally published in The Rose Sheet
Executive Summary
Hawaiian Tropic marketer Tanning Research Labs adds its voice to industry requests that FDA eliminate SPF 30+ cap on sunscreen, claiming there should be no restriction at "such a low level of protection" in an Oct. 14 citizen petition. Daytona Beach, Fla. firm cites strong sales of high-level SPF products as reason to eliminate cap, noting American consumers demand such products. Limit could remove incentive for manufacturers to develop more effective sunscreen products or encourage companies to use minimum amount of sunscreen actives to obtain the 30+ label, firm says...
You may also be interested in...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.